Swerdlow S, Campo E, Harris N.L, Jaffe E.S, Pileri S, Stein H, Thiele J, Arber D.A, Hasserjian R, Le Beau M.M, Orazi A, Siebert R. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. vol. 2. Revised 4th Edition. IARC, 2017

Sakata-Yanagimoto M. Enami T. Yoshida K. Shiraishi Y. Ishii R. Miyake Y. et al.

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

Nat Genet. 46: 171-175Palomero T. Couronné L. Khiabanian H. Kim M.-Y. Ambesi-Impiombato A. Perez-Garcia A. Carpenter Z. Abate F. Allegretta M. Haydu J.E. Jiang X. Lossos I.S. Nicolas C. Balbin M. Bastard C. Bhagat G. Piris M.A. Campo E. Bernard O.A. Rabadan R. Ferrando A.A.

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.

Nat Genet. 46: 166-170Yoo H.Y. Sung M.K. Lee S.H. Kim S. Lee H. Park S. Kim S.C. Lee B. Rho K. Lee J.-E. Cho K.-H. Kim W. Ju H. Kim J. Kim S.J. Kim W.S. Lee S. Ko Y.H.

A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.

Nat Genet. 46: 371-375Parrilla Castellar E.R. Jaffe E.S. Said J.W. Swerdlow S.H. Ketterling R.P. Knudson R.A. Sidhu J.S. Hsi E.D. Karikehalli S. Jiang L. Vasmatzis G. Gibson S.E. Ondrejka S. Nicolae A. Grogg K.L. Allmer C. Ristow K.M. Wilson W.H. Macon W.R. Law M.E. Cerhan J.R. Habermann T.M. Ansell S.M. Dogan A. Maurer M.J. Feldman A.L.

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

Blood. 124: 1473-1480Pedersen MB ard Hamilton-Dutoit S.J. Bendix K. Ketterling R.P. Bedroske P.P. Luoma I.M. Sattler C.A. Boddicker R.L. Bennani N.N. Nørgaard P.

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.

Blood. 130: 554-557Gambacorti-Passerini C. Messa C. Pogliani E.M.

Crizotinib in Anaplastic Large-Cell Lymphoma.

N Engl J Med. 364: 775-776

Swerdlow S, Campo E, Harris N.L, Jaffe E.S, Pileri S, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (IARC WHO Classification of Tumours). 4th Edition. 2008

Fusion Transcripts Identified in Angioimmunoblastic T Cell Lymphoma.

Mod Pathol. : 330ARohr J. Guo S. Huo J. Bouska A. Lachel C. Li Y. Simone P.D. Zhang W. Gong Q. Wang C. Cannon A. Heavican T. Mottok A. Hung S. Rosenwald A. Gascoyne R. Fu K. Greiner T.C. Weisenburger D.D. Vose J.M. Staudt L.M. Xiao W. Borgstahl G.E.O. Davis S. Steidl C. McKeithan T. Iqbal J. Chan W.C.

Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Leukemia. 30: 1062-1070Kataoka K. Nagata Y. Kitanaka A. Shiraishi Y. Shimamura T. Yasunaga J. et al.

Integrated molecular analysis of adult T cell leukemia/lymphoma.

Nat Genet. 47: 1304-1315Pechloff K. Holch J. Ferch U. Schweneker M. Brunner K. Kremer M. Sparwasser T. Quintanilla-Martinez L. Zimber-Strobl U. Streubel B.

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.

J Exp Med. 207: 1031-1044Streubel B. Vinatzer U. Willheim M. Raderer M. Chott A.

Novel t (5; 9)(q33; q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.

Leukemia. 20: 313-318Boddicker R.L. Razidlo G.L. Dasari S. Zeng Y. Hu G. Knudson R.A. Greipp P.T. Davila J.I. Johnson S.H. Porcher J.C. Smadbeck J.B. Eckloff B.W. Billadeau D.D. Kurtin P.J. McNiven M.A. Link B.K. Ansell S.M. Cerhan J.R. Asmann Y.W. Vasmatzis G. Feldman A.L.

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.

Blood. 128: 1234-1245Abate F. da Silva-Almeida A.C. Zairis S. Robles-Valero J. Couronne L. Khiabanian H. Quinn S.A. Kim M.-Y. Laginestra M.A. Kim C. Fiore D. Bhagat G. Piris M.A. Campo E. Lossos I.S. Bernard O.A. Inghirami G. Pileri S. Bustelo X.R. Rabadan R. Ferrando A.A. Palomero T.

Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.

Proc Natl Acad Sci. 114: 764-769Fujisawa M. Sakata-Yanagimoto M. Nishizawa S. Komori D. Gershon P. Kiryu M. Tanzima S. Fukumoto K. Enami T. Muratani M. Yoshida K. Ogawa S. Matsue K. Nakamura N. Takeuchi K. Izutsu K. Fujimoto K. Teshima T. Miyoshi H. Gaulard P. Ohshima K. Chiba S.

Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma.

Leukemia. 32: 694-702Boi M. Zucca E. Inghirami G. Bertoni F.

Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.

Br J Haematol. 168: 771-783Crescenzo R. Abate F. Lasorsa E. Tabbo’ F. Gaudiano M. Chiesa N. et al.

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma.

Cancer Cell. 27: 516-532Scarfò I. Pellegrino E. Mereu E. Kwee I. Agnelli L. Bergaggio E. Garaffo G. Vitale N. Caputo M. Machiorlatti R. Circosta P. Abate F. Barreca A. Novero D. Mathew S. Rinaldi A. Tiacci E. Serra S. Deaglio S. Neri A. Falini B. Rabadan R. Bertoni F. Inghirami G. Piva R. the European Cell Lymphoma Study Group T.-

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

Blood. 127: 221-232Hu G. Dasari S. Asmann Y.W. Greipp P.T. Knudson R.A. Benson H.K. Li Y. Eckloff B.W. Jen J. Link B.K. Jiang L. Sidhu J.S. Wellik L.E. Witzig T.E. Bennani N.N. Cerhan J.R. Boddicker R.L. Feldman A.L.

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.

Leukemia. 32: 565-569Vallois D. Dupuy A. Lemonnier F. Allen G. Missiaglia E. Fataccioli V. Ortonne N. Clavert A. Delarue R. Rousselet M.-C. Fabiani B. Llamas-Gutierrez F. Ogawa S. Thome M. Ko Y.H. Kataoka K. Gaulard P. de Leval L.

RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.

Haematologica. 103 ()Andrew L. Law Mark E. Ansell Stephen M. Johnson Sarah H. Porcher Julie C. Ozsan Nazan Wieben Eric D. Eckloff Bruce W. George Vasmatzis Feldman, 1, Ahmet Dogan, 1, David I. Smith

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Blood. 117: 915-919King R.L. Dao L.N. McPhail E.D. Jaffe E.S. Said J. Swerdlow S.H. Sattler C.A. Ketterling R.P. Sidhu J.S. Hsi E.D. others

Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements.

Am J Surg Pathol. 40: 36-43Onaindia A. de Villambrosía S.G. Prieto-Torres L. Rodríguez-Pinilla S.M. Montes-Moreno S. González-Vela C. Piris M.A.

DUSP22 -rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.

Haematologica. 104: e158-e162Luchtel R.A. Dasari S. Oishi N. Pedersen M.B. Hu G. Rech K.L. Ketterling R.P. Sidhu J. Wang X. Katoh R. Dogan A. Kip N.S. Cunningham J.M. Sun Z. Baheti S. Porcher J.C. Said J.W. Jiang L. Hamilton-Dutoit S.J. Møller M.B. Nørgaard P. Bennani N.N. Chng W.-J. Huang G. Link B.K. Facchetti F. Cerhan J.R. d’Amore F. Ansell S.M. Feldman A.L.

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

Blood. 132: 1386-1398Luchtel R.A. Zimmermann M.T. Hu G. Dasari S. Jiang M. Oishi N. Jacobs H.K. Zeng Y. Hundal T. Rech K.L. Ketterling R.P. Lee J.-H. Eckloff B.W. Yan H. Gaonkar K.S. Tian S. Ye Z. Kadin M.E. Sidhu J. Jiang L. Voss J. Link B.K. Syrbu S.I. Facchetti F. Bennani N.N. Slager S.L. Ordog T. Kocher J.-P. Cerhan J.R. Ansell S.M. Feldman A.L.

Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma.

Blood. 133: 2776-2789Hapgood G. Ben‐Neriah S. Mottok A. Lee D.G. Villa D. Sehn L.H. Connors J.M. Gascoyne R.D. Feldman A.L. Farinha P. Steidl C. Scott D.W. Slack G.W. Savage K.J.

Identification of high‐risk DUSP22‐rearranged ALK‐negative anaplastic large cell lymphoma.

Br J Haematol. ()Ruminy P. Marchand V. Buchbinder N. Larson T. Joly B. Penther D. Lemasle E. Lepretre S. Angot E. Mareschal S. Viailly P.-J. Dubois S. Clatot F. Viennot M. Bohers E. Rizzo D. Cornic M. Bertrand P. Girod C. Camus V. Etancelin P. Buchonnet G. Schneider P. Picquenot J.-M. Vannier J.-P. Bastard C. Tilly H. Jardin F.

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

Leukemia. 30: 757-760Bobée V. Drieux F. Marchand V. Sater V. Veresezan L. Picquenot J.-M. Viailly P.-J. Lanic M.-D. Viennot M. Bohers E. Oberic L. Copie-Bergman C. Molina T.J. Gaulard P. Haioun C. Salles G. Tilly H. Jardin F. Ruminy P.

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma.

Blood Cancer J. 10: 59Gong Q. Wang C. Rohr J. Feldman A.L. Chan W.C. McKeithan T.W.

Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.

Haematologica. 101: e269-e270Yoo H.Y. Kim P. Kim W.S. Lee S.H. Kim S. Kang S.Y. Jang H.Y. Lee J.-E. Kim J. Kim S.J. Ko Y.H. Lee S.

Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.

Haematologica. 101: 757-763Attygalle A.D. Feldman A.L. Dogan A.

ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.

Am J Surg Pathol. 37: 1456-1457Vasmatzis G. Johnson S.H. Knudson R.A. Ketterling R.P. Braggio E. Fonseca R. Viswanatha D.S. Law M.E. Kip N.S. Ozsan N. Grebe S.K. Frederick L.A. Eckloff B.W. Thompson E.A. Kadin M.E. Milosevic D. Porcher J.C. Asmann Y.W. Smith D.I. Kovtun I.V. Ansell S.M. Dogan A. Feldman A.L.

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

Blood. 120: 2280-2289Morris S. Kirstein M. Valentine M. Dittmer K. Shapiro D. Saltman D. Look A.

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma.

Science. 263: 1281-1284Lamant L. Dastugue N. Pulford K. Delsol G. Mariame B.

A New Fusion Gene TPM3-ALK in Anaplastic Large Cell Lymphoma Created by a (1;2)(q25;p23) Translocation.

Blood. 93: 3088-3095Trinei M. Lanfrancone L. Campo E. Pulford K. Mason D.Y. Pelicci P.-G. Falini B.

A New Variant Anaplastic Lymphoma Kinase (ALK)-Fusion Protein (ATIC-ALK) in a Case of ALK-positive Anaplastic Large Cell Lymphoma.

Cancer Res. 60: 793-798Hernández L. Pinyol M. Hernández S. Beà S. Pulford K. Rosenwald A. Lamant L. Falini B. Ott G. Mason D.Y. Delsol G. Campo E.

TRK-Fused Gene (TFG) Is a New Partner of ALK in Anaplastic Large Cell Lymphoma Producing Two Structurally DifferentTFG-ALK Translocations.

Blood. 94: 3265-3268Touriol C. Greenland C. Lamant L. Pulford K. Mason D.Y. Delsol G.

Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like).

Blood. 95: 3204-3207Tort F. Pinyol M. Pulford K. Roncador G. Hernandez L. Nayach I. Kluin-Nelemans H.C. Kluin P. Touriol C. Delsol G. Mason D. Campo E.

Molecular Characterization of a New ALK Translocation Involving Moesin (MSN-ALK) in Anaplastic Large Cell Lymphoma.

Lab Invest. 81: 419-426Cools J. Wlodarska I. Somers R. Mentens N. Pedeutour F. Maes B. De Wolf-Peeters C. Pauwels P. Hagemeijer A. Marynen P.

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor: Identification of Novel ALK Fusion Partners.

Genes Chromosomes Cancer. 34: 354-362Lamant L. Gascoyne R.D. Duplantier M.M. Armstrong F. Raghab A. Chhanabhai M. Rajcan-Separovic E. Raghab J. Delsol G. Espinos E.

Non-muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma.

Genes Chromosomes Cancer. 37: 427-432Feldman A.L. Vasmatzis G. Asmann Y.W. Davila J. Middha S. Eckloff B.W. Johnson S.H. Porcher J.C. Ansell S.M. Caride A.

Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma: TRAF1-ALK Fusion in ALCL.

Genes Chromosomes Cancer. 52: 1097-1102Palacios G. Shaw T.I. Li Y. Singh R.K. Valentine M. Sandlund J.T. Lim M.S. Mullighan C.G. Leventaki V.

Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex.

Leukemia. 31: 743-747Nagel S. Pommerenke C. MacLeod R.A.F. Meyer C. Kaufmann M. Fähnrich S. Drexler H.G.

Deregulated expression of NKL homeobox genes in T-cell lymphomas.

Oncotarget. 10: 3227-3247Sharma A. Oishi N. Boddicker R.L. Hu G. Benson H.K. Ketterling R.P. Greipp P.T. Knutson D.L. Kloft-Nelson S.M. He R. Eckloff B.W. Jen J. Nair A.A. Davila J.I. Dasari S. Lazaridis K.N. Bennani N.N. Wu T.-T. Nowakowski G.S. Murray J.A. Feldman A.L.

Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Blood. 131: 2262-2266Panagopoulos I. Gorunova L. Spetalen S. Bassarova A. Beiske K. Micci F. Heim S.

Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma.

Oncotarget. 8: 103775-103784Piton N. Ruminy P. Gravet C. Marchand V. Colasse É. Lamy A. Le Naoures Mear C. Bibeau F. Marguet F. Guisier F. Salaün M. Thiberville L. Jardin F. Sabourin J.-C.

Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma.

Lab Invest. 98: 371-379Van Roosbroeck K. Cox L. Tousseyn T. Lahortiga I. Gielen O. Cauwelier B. De Paepe P. Verhoef G. Marynen P. Vandenberghe P. De Wolf-Peeters C. Cools J. Wlodarska I.

JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma.

Blood. 117: 4056-4064Adélaïde J. Pérot C. Gelsi-Boyer V. Pautas C. Murati A. Copie-Bergman C. Imbert M. Chaffanet M. Birnbaum D. Mozziconacci M.-J.

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.

Leukemia. 20: 536-537Kakugawa K. Kojo S. Tanaka H. Seo W. Endo T.A. Kitagawa Y. Muroi S. Tenno M. Yasmin N. Kohwi Y. Sakaguchi S. Kowhi-Shigematsu T. Taniuchi I.

Essential Roles of SATB1 in Specifying T Lymphocyte Subsets.

Cell Rep. 19: 1176-1188Zelenka T. Spilianakis C.

SATB1-mediated chromatin landscape in T cells.

Nucleus. 11: 117-131Falini B. Pulford K. Pucciarini A. Carbone A. DeWolf-Peeters C. Cordell J. Fizzotti M. Santucci A. Pelicci P.-G. Pileri S. Campo E. Ott G. Delsol G. Mason D.Y.

Lymphomas Expressing ALK Fusion Protein(s) Other Than NPM-ALK.

Blood. 94: 3509-3515Agarwal I. Sabatini L. Alikhan M.B.

Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma.

Front Oncol. 10: 730Yoshida N. Shigemori K. Donaldson N. Trevisani C. Cordero N.A. Stevenson K.E. Bu X. Arakawa F. Takeuchi M. Ohshima K. Yoda A. Ng S.Y. Weinstock D.M.

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.

Blood. 135: 1467-1471Streubel B. Vinatzer U. Willheim M. Raderer M. Chott A.

Novel t (5; 9)(q33; q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.

Leukemia. 20: 313-318